patent office

A government bureau that grants applications for patents.

American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.

Patent Office

(ˈpætənt)

1. (Government, Politics & Diplomacy) a government department that issues patents. Abbreviation: Pat. Off

2. (Law) a government department that issues patents. Abbreviation: Pat. Off

Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014

ThesaurusAntonymsRelated WordsSynonymsLegend:

Noun

Patent Office - the government bureau in the Department of Commerce that keeps a record of patents and trademarks and grants new ones

Patent and Trademark Office Database

Commerce Department, Department of Commerce, DoC, Commerce - the United States federal department that promotes and administers domestic and foreign trade (including management of the census and the patent office); created in 1913

bureau, federal agency, government agency, agency, office, authority - an administrative unit of government; "the Central Intelligence Agency"; "the Census Bureau"; "Office of Management and Budget"; "Tennessee Valley Authority"

Translations

Patent Office

n the Patent Office → l'ufficio brevetti

Collins Italian Dictionary 1st Edition © HarperCollins Publishers 1995

Mentioned in

References in classic literature

That reminds me to remark, in passing, that the very first official thing I did, in my adminis- tration -- and it was on the very first day of it, too -- was to start a patent office; for I knew that a country without a patent office and good patent laws was just a crab, and couldn't travel any way but sideways or backways.

The first thing you want in a new country, is a patent office; then work up your school system; and after that, out with your paper.

View in context

In describing it to the officials of the Patent Office, he was obliged to call it "an improvement in telegraphy," when, in truth, it was nothing of the kind.

View in context

The Patent Office at Washington, furnishes an extraordinary example of American enterprise and ingenuity; for the immense number of models it contains are the accumulated inventions of only five years; the whole of the previous collection having been destroyed by fire.

John's Wood; put green blinds outside all the private houses, with a red curtain and a white one in every window; plough up all the roads; plant a great deal of coarse turf in every place where it ought NOT to be; erect three handsome buildings in stone and marble, anywhere, but the more entirely out of everybody's way the better; call one the Post Office; one the Patent Office, and one the Treasury; make it scorching hot in the morning, and freezing cold in the afternoon, with an occasional tornado of wind and dust; leave a brick-field without the bricks, in all central places where a street may naturally be expected: and that's Washington.

View in context

In January, Shield announced that a third party had raised objections with the European Patent Office over Shield patents 2 668 175 and 3 160 951 covering a "process for preparing an iron hydroxypyrone".

Teva Appeals Shield Therapeutics European Drug Patent Win

Diffusion Pharmaceuticals announced receipt from the European Patent Office of a notice of intention to grant a patent related to the use of the company's compound trans sodium crocetinate, or TSC, in combination with the leading thrombolytic, tissue plasminogen activator, or tPA, in the treatment of ischemic stroke.

Diffusion Pharmaceuticals granted three patents from the European Patent Office

M2 PHARMA-April 24, 2019-US Patent Office Grants Charpentier/Doudna Key CRISPR Patent

US Patent Office Grants Charpentier/Doudna Key CRISPR Patent

M2 EQUITYBITES-February 18, 2019-Regeneron reports decisions from the US and EU Patent Office to invalidate Immunex patents claiming antibodies to the IL-4 receptor

Regeneron reports decisions from the US and EU Patent Office to invalidate Immunex patents claiming antibodies to the IL-4 receptor

Global Banking News-February 18, 2019-Regeneron reports decisions from the US and EU Patent Office to invalidate Immunex patents claiming antibodies to the IL-4 receptor

Regeneron reports decisions from the US and EU Patent Office to invalidate Immunex patents claiming antibodies to the IL-4 receptor

We drafted a provisional patent application which holds your place in line at the patent office, then after a year you have to convert that to a regular utility patent application.

A sidebar with Brent Seitz